Finafloxacin is a potent fluoroquinolone antibiotic specifically indicated for the treatment of acute otitis externa caused by susceptible bacterial strains such as Pseudomonas aeruginosa and Staphylococcus… Read more
Finafloxacin is a potent fluoroquinolone antibiotic specifically indicated for the treatment of acute otitis externa caused by susceptible bacterial strains such as Pseudomonas aeruginosa and Staphylococcus aureus. This category provides access to high-quality reference standards for Finafloxacin and its hydrochloride salt, which are essential for verifying active pharmaceutical ingredient identity and assay purity in quality control laboratories. Researchers and analytical chemists utilize these materials, along with a range of related process impurities, degradation products, and stable isotope labelled compounds, to support robust impurity profiling and method validation. By incorporating these precise analytical standards into pharmacopoeial testing and routine laboratory workflows, pharmaceutical teams can ensure compliance with regulatory requirements, effectively detect trace-level contaminants, and support the ongoing development of reliable, sensitive analytical methods for this critical antibiotic therapy.